Taro Pharmaceutical Industries

News across the web »
Interact & exchange stock tips & market info »

Vishal K

New Member

0 Follower

Web Messenger

Platinum Member

107841 Followers

Related News »
The new fiscal year end was effectuated to align Taro's fiscal reporting period and its annual budget planning with that of its major shareholder, Sun Pharmaceutical Industries Ltd. ("Sun Pharma," Reuters: SUN.BO, Bloomberg: SUNP IN, NSE ...
May 24, 2012 at 20:22 | Source: Marketwatch
(RTTNews) - Taro Pharmaceutical Industries Ltd. (TARO: News ) Thursday reported an increase in profit for the first quarter, as revenue surged and margins improved. Net income attributable to Taro improved to $47.3 million or $1.06 per share, compared to $ ...
May 24, 2012 at 22:17 | Source: RTT News
Mumbai: Drug maker Sun Pharmaceutical Industries Ltd’s Israeli subsidiary Taro Pharmaceutical Industries Ltd almost doubled its net profit to $47.3 million in the January-March quarter. The company had posted a net profit of $25.7 million in the year-ago period.
May 25, 2012 at 09:16 | Source: Livemint.com
Taro Pharmaceutical Industries Ltd. (NYSE: TARO, “Taro”) announced that its Annual Report for the fiscal year ended December 31, 2011 on Form 20-F, filed with the Securities and Exchange Commission (the “SEC”) on April 5, 2012 ...
May 11, 2012 at 14:40 | Source: Yahoo Finance
Special Committee of the Board of Directors of Taro Pharmaceutical Industries Ltd. Evaluating Sun Acquisition Proposal Euro Park (Italy Building) Yakum Business Park, Yakum 60972, Israel Attention: Professor Dov Pekelman, Chairman of the Special Committee ...
May 9, 2012 at 23:53 | Source: PR-USA.net